Global Hospital & Biosimilars Health System Director East

Role Summary

Hospital & Biosimilars Health System Directors are responsible for working with other HSDs, Field Sales, Marketing, NADs, TADs Contract Development team, Pricing and Commercial Operations team and Strategy and Deployment team and relevant HQ teams to support effective and compliant pricing and contracting discussions with Key Accounts, in support of the biosimilar portfolio. HSDs engage appropriate executive and administrative customers in Key Accounts to secure formulary access and appropriate pull through, with a focus on economic decision makers. This includes negotiating with customers and coordinating with HQ functions to support GPO, IDN and Distributor Source contracts. They develop hospital/biosimilar strategies, lead pull-through efforts, and participate in regional cross-functional teams to maximize opportunities and address challenges within assigned accounts.

Responsibilities

• Appropriate communication and collaboration with cross-functional colleagues to support effective pricing/contracting strategy/discussions with Hospital & Biosimilars Key Accounts.
• Develop and execute focused, strategic account plans for all assigned accounts, emphasizing compliant contracting discussions and contract pull-through.
• Engage executive and administrative level personnel within HSD accounts with respect to pricing/value messages in support of the full Hospital & Biosimilars portfolio.
• Support the development/execution of effective contracting strategy for the full Biosimilars portfolio by representing the needs/perspectives of HSD accounts to HQ-based functions.
• Comply with all corporate policies and procedures while maintaining high standards of business conduct.

Qualifications

• Required: 8 years of progressive experience in pharmaceutical sales, medical affairs, and/or corporate account management with customer-facing equivalence.
• Including a minimum 3–5 years of direct biosimilars and Generic Sterile Injectables experience, including buy-and-bill strategies and knowledge of regulatory pathways (FDA, EMA, Health Canada) and interchangeability requirements.
• Manufacturing and quality standards for biologics and generic sterile injectables, including comparability exercises.
• Commercialization strategies, market access, IDN and alternate site clinic negotiations, and formulary inclusion for biosimilars.
• Pharmacovigilance and post-market safety monitoring.
• Preferred: Oncology and/or Immunology & Inflammation therapeutic area expertise.
• Proven success engaging Academic Medical Centers, IDNs, and large group practice community accounts.
• Strong understanding of the evolving US healthcare landscape and impact on organized provider accounts/customers.
• Strong financial acumen and ability to deliver complex pricing/value messages in a compliant manner.
• Demonstrated ability to engage executive/administrative personnel at large accounts and achieve customer impact.
• Strategic thinking with ability to formulate, develop, communicate, and monitor stakeholder business plans.
• Experience in executing and overseeing complex programs and projects; strong project management skills.
• Proven ability to collaborate across the organization and lead cross-functional teams.

Education

• Bachelor’s Degree required
• MBA or relevant graduate degree preferred